IQLT - ETF AI Analysis

Top Page

iShares MSCI Intl Quality Factor ETF (IQLT)

Rating:68Neutral

Price Target:―

IQLT, the iShares MSCI Intl Quality Factor ETF, earns a solid overall rating because it is built around financially strong, high-quality global companies. Major holdings like Novartis, AstraZeneca, ASML, ABB, and Zurich Insurance support the fund’s quality focus with robust profitability, positive earnings sentiment, and generally healthy balance sheets, even if some look expensive or show mixed technical signals. The main risk is that several key holdings face valuation concerns or bearish/overbought technical trends, and the fund is meaningfully exposed to a handful of large positions, so short-term price swings in these names can affect the ETF’s performance.

Positive Factors

Strong Recent Performance

The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.

Quality Leaders in Top Holdings

Several major positions, such as ASML and Roche, have delivered strong or steady performance, helping support the fund’s overall returns.

Broad International Diversification

Holdings spread across many countries and sectors, with no single country or industry dominating, help reduce the impact of local or sector-specific downturns.

Negative Factors

Mixed Performance Among Top Holdings

Some large positions, including Allianz, Shell, AstraZeneca, Nestlé, and Zurich Insurance Group, have shown weak or negative performance, which can drag on the fund.

Heavy Financial Sector Exposure

A sizable allocation to financial stocks means the ETF may be more sensitive to interest rate changes and financial sector stress.

Moderate Expense Ratio

The fund’s expense ratio is not especially low for a large ETF, so fees may slightly reduce long-term returns compared with the cheapest alternatives.

IQLT vs. SPDR S&P 500 ETF (SPY)

AUM12.02B

RegionDeveloped Markets

Expense Ratio0.30%

Beta0.72

IssueriShares

Inception DateJan 13, 2015

Dividend Yield2.3%

Asset ClassEquity

Index TrackedWorld ex USA Sector Neutral Quality

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume2,476,107

30 Day Avg. Volume2,606,298

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

51.93

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering290

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

IQLT Summary

IQLT is the iShares MSCI Intl Quality Factor ETF, which follows the MSCI World ex USA Sector Neutral Quality index. It invests in “high-quality” companies from developed countries outside the U.S., focusing on firms with strong finances and steady earnings. The fund holds well-known names like Nestlé and AstraZeneca, and spreads money across many sectors such as financials, industrials, and technology. Someone might invest in IQLT to diversify beyond the U.S. and seek long-term growth from solid international companies. A key risk is that international stock prices can go up and down with global markets and currency moves.

How much will it cost me?The iShares MSCI Intl Quality Factor ETF (IQLT) has an expense ratio of 0.30%, which means you’ll pay $3 per year for every $1,000 invested. This is slightly higher than average for passively managed ETFs because it focuses on a specific strategy of selecting high-quality international stocks, which requires more specialized research and management.

What would affect this ETF?The iShares MSCI Intl Quality Factor ETF (IQLT) could benefit from continued global economic growth and increased demand for high-quality companies in developed markets outside the U.S., particularly in sectors like financials, technology, and healthcare. However, it may face challenges from rising interest rates, which could pressure profitability in certain sectors, and geopolitical risks or regulatory changes in key regions that could impact its top holdings like ASML, Shell, and Nestlé. Diversification across sectors and countries helps mitigate some risks but does not eliminate them entirely.

IQLT Top 10 Holdings

IQLT is leaning heavily on a handful of high‑quality European champions, with ASML in the driver’s seat as a rising star powering much of the fund’s recent strength. Health care is another key engine: Roche, Novartis, and AstraZeneca have all been climbing steadily, giving the portfolio a defensive but productive core. Industrial names like ABB and Schneider Electric are also humming along, adding cyclical punch. On the flip side, insurers Allianz and Zurich are losing a bit of steam, modestly dragging on an otherwise solid, developed‑markets‑ex‑U.S. lineup.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
ASML	ASML Holding NV	5.97%	$712.98M	€450.59B	80.13%	76 Outperform
SHEL	Shell (UK)	2.62%	$312.66M	£189.65B	27.87%	73 Outperform
NOVN	Novartis AG	2.47%	$295.20M	CHF230.97B	25.96%	80 Outperform
ALV	Allianz	2.32%	$277.30M	€134.10B	0.55%	67 Neutral
ROG	Roche Holding AG	2.28%	$272.21M	CHF256.31B	21.75%	73 Outperform
AZN	AstraZeneca	2.15%	$256.75M	$295.20B	19.89%	80 Outperform
NESN	Nestlé SA	2.11%	$252.49M	CHF204.54B	-0.11%	71 Outperform
ABB	ABB Ltd	1.98%	$236.38M	kr1.44T	36.87%	78 Outperform
ZURN	Zurich Insurance Group	1.66%	$198.19M	CHF80.39B	-0.33%	78 Outperform
SU	Schneider Electric	1.49%	$177.36M	€139.68B	10.37%	62 Neutral

IQLT Technical Analysis

Technical Analysis Sentiment

Negative

Last Price―

Price Trends

50DMA

47.67

Negative

100DMA

46.08

Negative

200DMA

44.43

Positive

Market Momentum

MACD

-0.40

Positive

RSI

33.97

Neutral

STOCH

20.38

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IQLT, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 48.17, equal to the 50-day MA of 47.67, and equal to the 200-day MA of 44.43, indicating a neutral trend. The MACD of -0.40 indicates Positive momentum. The RSI at 33.97 is Neutral, neither overbought nor oversold. The STOCH value of 20.38 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IQLT.

IQLT Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
IQLT	―	―	$12.02B	0.30%	68 Neutral
VEA	―	―	$205.58B	0.03%	60 Neutral
SCHF	―	―	$58.38B	0.03%	63 Neutral
SPDW	―	―	$36.86B	0.03%	62 Neutral
IDEV	―	―	$27.69B	0.04%	66 Neutral
DFAI	―	―	$14.69B	0.18%	64 Neutral

Performance Comparison

IQLT

iShares MSCI Intl Quality Factor ETF

45.97

5.95

14.87%

VEA

Vanguard FTSE Developed Markets ETF

―

SCHF

Schwab International Equity ETF

―

SPDW

SPDR Portfolio Developed World ex-US ETF

―

IDEV

iShares Core MSCI International Developed Markets ETF

―

DFAI

Dimensional International Core Equity Market ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents